Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children

Abstract

Inflammation and organ failure strongly reduce midazolam clearance, a surrogate marker of CYP3A-mediated drug metabolism, in critically ill children. Hence, critically ill patients receiving CYP3A substrate drugs may be at risk of increased drug levels and associated toxicity.